Learn about the Blue Jet Healthcare Limited IPO, a prescription for success in the pharmaceutical and healthcare industry. Discover IPO details, business model, and more.
Blue Jet Healthcare Limited is making waves in the pharmaceutical and healthcare industry. Learn about their business model, global reach, and IPO details in this comprehensive article.
Blue Jet Healthcare Limited is soaring high in the pharmaceutical and healthcare ingredients and intermediates industry. As they prepare to launch their maiden public issue, let’s dive into what makes this company stand out.
Business Model: Innovating Pharmaceutical Manufacturing
Blue Jet operates as a Contract Development and Manufacturing Organization (CDMO), specializing in pharmaceutical and healthcare ingredient production. They focus on niche products to serve both innovator and multinational generic pharmaceutical companies.
Core Competencies: Specialized Chemistry Pioneers
This company has invested strategically in research and development (R&D) and manufacturing infrastructure. Their specialized chemistry capabilities revolve around contrast media intermediates and high-intensity sweeteners.
Product Range: Quality and Control
Blue Jet manufactures a wide range of products in-house, including key starting intermediates and advanced intermediates. This in-house production ensures consistent product quality and cost-effectiveness.
Also read: Chandrayaan-3: The Sleeping Giants on the Lunar Horizon
Global Reach: Connecting Worldwide
Over the past three financial years, Blue Jet has conducted business with more than 350 customers in 35 countries. Their loyal customer base, often engaged through long-term contracts, includes innovator pharmaceutical companies and multinational generic pharmaceutical companies.
Collaboration, Development, Manufacturing Approach: Key to Success
The company’s “Collaboration, Development, Manufacturing” approach involves working closely with customers to create tailored solutions and products. This approach has been pivotal in growing their CDMO business.
Product Categories: Delivering Excellence
Blue Jet’s operations are organized into three primary product categories:
- Contrast Media Intermediates: Essential for medical imaging, such as X-ray or MRI contrast agents.
- High-Intensity Sweeteners: Focus on sweetening agents like saccharin and its salts.
- Pharma Intermediates and APIs: Vital components of drug formulations.
Competitive Strengths:
- A leading manufacturer of contrast media intermediates in India.
- Presence in niche categories with high barriers to entry.
- Long-standing relationships and multi-year contracts with multinational customers.
Blue Jet Healthcare Limited IPO Details:
- Open Date: October 25, 2023
- Close Date: October 27, 2023
- Total Shares: 24,285,160
- Face Value: ₹ 2 Per Equity Share
- Issue Type: Book Built Issue IPO
- Issue Size: ₹ 840.27 Cr.
- Lot Size: 43 Shares
- Issue Price: ₹ 329 to ₹ 346 Per Equity Share
- Listing At: NSE, BSE
- Listing Date: November 6, 2023
To apply for IPO open a Demat account with Angel One by click here!
Promoters and Management:
- Akshay Bansarilal Arora: Executive Chairman with over three decades of experience.
- Shiven Akshay Arora: Managing Director overseeing finance, macro management, and strategic matters.
- Naresh Suryakant Shah: Executive Director with extensive experience in sales, marketing, and commercial activities.
Financials of Blue Jet Healthcare Limited IPO:
A. Balance Sheet
- Total Liabilities (Mar-21): ₹ 1,965 million
- Total Liabilities (Mar-22): ₹ 1,918 million
- Total Liabilities (Mar-23): ₹ 1,806 million
B. Profit & Loss Statement
- Net Profit Margin (Mar-21): 26.74%
- Net Profit Margin (Mar-22): 25.84%
- Net Profit Margin (Mar-23): 21.48%
Also read: Unlocking the Potential: Ondoor Concepts IPO Review
C. Cash Flow Statement
- Net Cash Inflow from Operating Activity (Mar-21): ₹ 1,293 million
- Net Cash Inflow from Operating Activity (Mar-22): ₹ 1,464 million
- Net Cash Inflow from Operating Activity (Mar-23): ₹ 1,416 million
Lead Manager of Blue Jet Healthcare Limited IPO:
- ICICI Securities Limited
- J.P. Morgan India Private Limited
- Kotak Mahindra Capital Company Limited
Registrar of Blue Jet Healthcare Limited IPO:
- Link Intime India Private Limited
Blue Jet Healthcare Limited is set to make a remarkable entry into the market with its IPO. Their commitment to innovation and excellence in pharmaceutical manufacturing is evident. Investors and healthcare enthusiasts should keep a close eye on this prescription for success.
2 thoughts on “Blue Jet Healthcare Limited IPO: A Prescription for Success (On 25th Oct)”